Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$92.57 - $107.37 $73,778 - $85,573
-797 Reduced 86.91%
120 $12,000
Q4 2023

Jan 22, 2024

BUY
$92.27 - $101.54 $84,611 - $93,112
917 New
917 $92,000
Q1 2022

May 03, 2022

SELL
$80.11 - $90.62 $6,969 - $7,883
-87 Reduced 1.59%
5,387 $473,000
Q4 2021

Jan 20, 2022

SELL
$79.7 - $88.13 $6,933 - $7,667
-87 Reduced 1.56%
5,474 $479,000
Q1 2021

Apr 13, 2021

SELL
$83.5 - $98.47 $12,358 - $14,573
-148 Reduced 2.59%
5,561 $475,000
Q4 2020

Jan 14, 2021

BUY
$78.07 - $94.43 $23,577 - $28,517
302 Added 5.59%
5,709 $539,000
Q3 2020

Oct 16, 2020

BUY
$82.14 - $91.0 $65,465 - $72,527
797 Added 17.29%
5,407 $470,000
Q1 2019

Apr 23, 2019

BUY
$75.32 - $86.15 $9,038 - $10,338
120 Added 2.67%
4,610 $390,000
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $16,868 - $18,782
229 Added 5.37%
4,490 $385,000
Q3 2018

Oct 12, 2018

BUY
$66.94 - $77.43 $24,566 - $28,416
367 Added 9.42%
4,261 $367,000
Q1 2018

Apr 24, 2018

BUY
$70.39 - $84.15 $7,672 - $9,172
109 Added 2.88%
3,894 $315,000
Q3 2017

Oct 25, 2017

BUY
$74.14 - $77.27 $280,619 - $292,466
3,785
3,785 $325,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.